Prophylactic Vaccine Strategies and the Potential of Therapeutic Vaccines Against Herpes Simplex Virus

E-ISSN： 1873-4286|13|19|1975-1988

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.19, 2007-07, pp. : 1975-1988

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential impact of a prophylactic herpes simplex vaccine

By Rupp Richard Bernstein David I

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 41-52

Informa Healthcare

Access to resources Recommend Favorite

High Therapeutic Potential for Systemic Delivery of a Liposomeconjugated Herpes Simplex Virus

Current Cancer Drug Targets, Vol. 11, Iss. 1, 2011-01 ,pp. : 111-122

Bentham Science Publishers

Access to resources Recommend Favorite

Vaccines and Vaccine Strategies Against HIV

Current Drug Targets, Vol. 5, Iss. 1, 2004-01 ,pp. : 71-88

Bentham Science Publishers

Access to resources Recommend Favorite

Oncotarget Strategies For Herpes Simplex Virus-1

Current Gene Therapy, Vol. 16, Iss. 2, 2016-04 ,pp. : 130-143

Bentham Science Publishers

Access to resources Recommend Favorite

Potential Prophylactic and Therapeutic Vaccines for HSV Infections

Current Pharmaceutical Design, Vol. 13, Iss. 19, 2007-07 ,pp. : 1965-1973

Bentham Science Publishers

Access to resources Recommend Favorite